This Tiny $220 Million Company is Poised to be the Leader in Personalized Medicine At under $2 a share this company will turn the high-tech drug market upside down. “?[The year 2000] began with 24 million Africans infected with the virus. In the absence of a medical miracle, nearly all will die before 2010. Each day, 6,000 [...]